Posted by Michael Wonder on 13 Oct 2021
Provisional determination granted to Pfizer's COVID-19 vaccine (Comirnaty) - proposed for use in children 5-11 years of age
13 October 2021 - On 12 October 2021, the Therapeutic Goods Administration granted a provisional determination to Pfizer in relation to its COVID-19 Vaccine, Comirnaty.
Currently, Comirnaty is provisionally approved for use in individuals 12 years of age or older. The granting of this determination means that Pfizer is now eligible to apply to vary the provisional approval for the vaccine to include children aged 5 to 11 years.
